Zobrazeno 1 - 10
of 114
pro vyhledávání: '"Morgan, Murray"'
Publikováno v:
Journal of the Scholarship of Teaching and Learning, Vol 24, Iss 1 (2024)
Required undergraduate diversity courses often expose students to topics and worldviews which may push them out of their comfort zones and prompt dissonance and even resistance. This paper reports on interviews with 68 faculty members at five predomi
Externí odkaz:
https://doaj.org/article/0d741171613d4e66b0713090e3c56721
Autor:
Michael Murphy, Anthony Dowling, Christopher Thien, Emma Priest, Donna Morgan Murray, Santosh Kesari
Publikováno v:
CNS Oncology, Vol 8, Iss 1 (2019)
Aim: Evaluation of the Nativis Voyager®, an investigational medical device, as monotherapy for recurrent glioblastoma (rGBM). Materials & methods: A total of 15 patients with rGBM were treated with one of two Voyager ultra-low radio frequency energy
Externí odkaz:
https://doaj.org/article/3be678ab449e4b319d86531ce3084496
Autor:
Charles Cobbs, Edward McClay, J Paul Duic, L Burt Nabors, Donna Morgan Murray, Santosh Kesari
Publikováno v:
CNS Oncology, Vol 8, Iss 1 (2019)
Aim: Evaluation of the Nativis Voyager® device in patients with recurrent glioblastoma (rGBM). Materials & methods: Voyager is a noninvasive, nonthermal, nonionizing and portable investigational device which delivers ultra-low radio frequency energy
Externí odkaz:
https://doaj.org/article/fa3e4c93c1534b618bb11c7cceb3aec3
Autor:
Janine LeBlanc-Straceski, Riley Williams, Kylie Ward, Autumn Bates, Catherine Duran, Lordina Anderson, Morgan Murray, Jennifer Pereira-Badji, Christina Shoushani, Jacob Thibault
In a cellular model of Down Syndrome, hTERT immortalized RPE-1 (human retinal pigment epithelial-1) cells carrying an extra copy of chromosome 21 exhibit reduced fitness, in part, as an increase in doubling time (or a reduction in cell proliferation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee6a25f44d625d57e7e686563fcdd241
https://doi.org/10.1101/2022.10.20.513071
https://doi.org/10.1101/2022.10.20.513071
Autor:
Erica Tobin, Pamela Sullivan, Morgan Murray, Hugh Gannon, Anne Dodson, Sol Shenker, Frank Stegmeier, Andrew Wylie, Louise Cadzow
Publikováno v:
Cancer Research. 83:1581-1581
Tumors harboring BRCA1/2 mutations and other homologous recombination deficiencies are sensitive to agents targeting pathways involved in DNA repair including poly (ADP-ribose) polymerase (PARP) inhibitors, which have been approved for the treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::63ae7c5105453ed40a63db2bd2018ca5
https://doi.org/10.1158/1538-7445.am2023-1581
https://doi.org/10.1158/1538-7445.am2023-1581
Autor:
Sumeet Nayak, Pamela Sullivan, Yuji Mishina, Anne Dodson, Pei-Lun Kao, Hugh Gannon, Chris Middleton, Sol Shenker, Morgan Murray, Michael Schlabach, Frank Stegmeier, Erica Tobin, Louise Cadzow, Andrew Wylie
Publikováno v:
Cancer Research. 83:2771-2771
Tumors with defects in DNA double strand break (DSB) repair pathways, including those with mutations in BRCA1/2, are often treated with either poly (ADP-ribose) polymerase-1 (PARP1) inhibitors or platinum-based chemotherapy. Despite their clinical be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55ed71f623d3a547b0b49dcefbb20be7
https://doi.org/10.1158/1538-7445.am2023-2771
https://doi.org/10.1158/1538-7445.am2023-2771
Autor:
Paul Beninger, Morgan Murray
Publikováno v:
Clinical therapeutics. 43(2)
Purpose Title IX, § 921 of the Food and Drug Administration (FDA) Amendments Act of 2007 requires the FDA to mine data on a regular basis, using its adverse events database, the FDA Adverse Event Reporting System, to identify potential signals of se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb6a838d40573a7956138145bf034aef
https://pubmed.ncbi.nlm.nih.gov/33504449
https://pubmed.ncbi.nlm.nih.gov/33504449